Evidence map›Paper›PMID 40682057›Full record

ArticleThrombosis journal2025

Utility of lower extremity ultrasound prior to application of serial compression device in patients with COVID-19: "choosing wisely" initiative at a major referral center in the Middle East.

Tedy Sawma, Joelle Hassanieh, Angie Fares, Hussein Kharroubi, Oussama Issa, Firas Kreidieh, Jamal J Hoballah

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Thrombosis journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tedy Sawma *Faculty of Medicine, American University of Beirut, Bliss Street, PO Box 11-0236, Beirut, Lebanon.
Joelle Hassanieh *Department of Surgery, American University of Beirut Medical Center, Bliss Street, PO Box 11-0236, Beirut, Lebanon.
Angie FaresFaculty of Medicine, American University of Beirut, Bliss Street, PO Box 11-0236, Beirut, Lebanon.
Hussein KharroubiFaculty of Medicine, American University of Beirut, Bliss Street, PO Box 11-0236, Beirut, Lebanon.
Oussama IssaFaculty of Medicine, American University of Beirut, Bliss Street, PO Box 11-0236, Beirut, Lebanon.
Firas KreidiehDivision of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Bliss Street, PO Box 11-0236, Beirut, Lebanon.
Jamal J HoballahDepartment of Surgery, American University of Beirut Medical Center, Bliss Street, PO Box 11-0236, Beirut, Lebanon. jh34@aub.edu.lb.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe link between venous thromboembolism (VTE) and coronavirus disease 2019 (COVID-19) infection has been consolidated by many studies in the literature. The increased risk of VTE among COVID-19 patients, on the one hand, and the morbidity that can be associated with the ICU course, on the other hand, promote quality care among this patient population. "Choosing wisely" is a quality improvement initiative that emphasizes the importance of assessing the utility of diagnostic tests. Our study was a "Choosing Wisely" single-center initiative aimed at assessing the utility of LEUS among COVID-19 patients who are treated at AUBMC, a major referral center in the Middle East.

methodsData from hospitalized COVID-19 patients who underwent LEUS during the pandemic between 2019 and 2021 at our institution were retrospectively analyzed. LEUS was ordered to screen for preexisting DVT prior to the application of mechanical DVT prophylaxis via a serial compression device (SCD) or to rule out suspected DVT. Data on patients' demographics, comorbidities, and mortality were also retrieved.

resultsA total of 179 patients were included in this study. The mean age of the patients was 66.09 ± 16.587 years, and 108 (60.3%) of our patients were men. Ninety-four (52.5%) patients underwent LEUS for asymptomatic DVT screening prior to SCD placement, and 84 (46.9%) patients underwent LEUS to rule out suspected DVT in the context of other causes, namely, prolonged hospital stay, immobilization, and other hypercoagulable risk factors. Among the 94 patients who underwent LEUS screening, 12 (12.76%) patients were found to have DVT, and SCD placement was consequently aborted. Half of these patients had an IVC filter placed afterward. A previous history of DVT or pulmonary embolism (PE) was strongly associated with DVT occurrence in ICU and non-ICU patients. The mortality rate was 88 (49.2%) among the studied population, which was the highest among the ICU patients (88 (69.8%) with p < 0.001).

conclusionCompared with the available literature, we report a greater incidence of asymptomatic DVT among COVID-19 patients, including those screened prior to SCD. We suggest that the clinical utility of LEUS for this patient population outweighs its cost and presumed low benefit. Prospective studies with larger sample sizes are needed to further assess the utility of LEUS and promote the "Choosing Wisely" initiative.

Indexed as

Choosing wiselyCOVID-19DVTICUSCDUltrasound

Identifiers

PMID40682057
PMCPMC12275248

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.